Nuvalent, INC Form 4 insider transactions

Matthew Shair, a director at Nuvalent, Inc., sold shares of Class A Common Stock on July 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Emily Conley exercised stock options and sold shares of Nuvalent, Inc. (NUVL) under a pre-arranged Rule 10b5-1 trading plan on July 15, 2024.

Deborah Ann Miller, Chief Legal Officer of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Henry E. Pelish, Chief Scientific Officer of Nuvalent, Inc., reports the acquisition of shares and stock options on July 9, 2024.

Deborah Ann Miller, Chief Legal Officer of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock on July 8, 2024, according to a Form 4 filing with the SEC.

Darlene Noci, Chief Development Officer of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock on July 1, 2024, according to a Form 4 filing with the SEC.

Alexandra Balcom, CFO of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock on June 28, 2024, according to a recent SEC Form 4 filing.

Director Matthew Shair of Nuvalent, Inc. executed sales of Class A Common Stock on June 24, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Emily Conley exercised stock options and sold Nuvalent (NUVL) shares on June 14, 2024, under a pre-arranged Rule 10b5-1 trading plan.

James E. Flynn, affiliated with Deerfield Management, reports changes in beneficial ownership of Nuvalent, Inc. stock due to stock options and restricted stock units (RSUs) granted to Deerfield Management's directors.

Director Andrew Hack reports acquisition of restricted stock units and stock options in Nuvalent, Inc.

Director Cameron Wheeler acquired shares and options in Nuvalent, Inc. on June 12, 2024, under restricted stock units and stock options.

Director Joseph Pearlberg reports acquisition of Nuvalent, Inc. Class A Common Stock and stock options.

Director Sapna Srivastava reported the acquisition of Nuvalent, Inc. Class A Common Stock and stock options.

Director Matthew Shair reports acquisition of stock and option awards in Nuvalent, Inc.

Director Anna Protopapas reports acquisition of Nuvalent, Inc. Class A Common Stock and stock options.

Director Michael L. Meyers reports acquisition of Nuvalent, Inc. Class A Common Stock and stock options.

Director Dwight Gary Gilliland acquired stock options and restricted stock units in Nuvalent, Inc.

Director Emily Conley reported the acquisition of stock and option awards in Nuvalent, Inc.

Deborah Ann Miller, Chief Legal Officer of Nuvalent, Inc., exercised stock options and sold Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan on June 6, 2024.

Matthew Shair, a director at Nuvalent, Inc., executed multiple sales of Class A Common Stock on May 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Emily Conley exercised stock options and sold shares of Nuvalent, Inc. Class A Common Stock on May 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Matthew Shair, a director at Nuvalent, Inc., sold shares of Class A Common Stock on May 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Matthew Shair sold shares of Nuvalent, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Deborah Ann Miller, Chief Legal Officer of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock on May 2, 2024, according to a recent SEC filing.

Matthew Shair, a director at Nuvalent, Inc., executed multiple sales of Class A Common Stock on April 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Matthew Shair sold shares of Nuvalent, Inc. (NUVL) under a pre-arranged Rule 10b5-1 trading plan.

Matthew Shair, a director at Nuvalent, Inc., sold shares of Class A Common Stock on April 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Emily Conley exercised stock options and sold shares of Nuvalent, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Director Matthew Shair of Nuvalent, Inc. executed multiple sales of Class A Common Stock on April 8, 2024, under a pre-arranged Rule 10b5-1 trading plan.